Cardiovascular Diseases Clinical Trial
Official title:
Epidemiology and Mechanisms of ECG Abnormalities: Young Adulthood to Middle Age
An electrocardiogram (ECG) is a test that evaluates the electrical activity of the heart and can be used to detect heart problems. By analyzing ECGs collected over a 20-year period, this study will examine ECG abnormalities and the differences in ECG findings between black and white people, from young adulthood through middle age.
An ECG is a test that detects and records the electrical activity of the heart. As a
diagnostic tool, it can detect and locate the source of heart problems, including heart
attacks, irregular heart beats, cardiovascular disease, or other abnormalities of the heart.
An ECG procedure involves attaching electrodes to the skin on the chest, arms, and legs
while the electrodes detect electrical signals of the heart, and a machine displays the
signals on a computer screen and graph paper. An ECG may be a beneficial way to detect
cardiovascular disease because it is a low-cost and non-invasive test that is widely
available in the clinical setting.
This study will examine ECGs and other study data from participants in the Coronary Artery
Risk Development in Young Adults (CARDIA) study. As ECG abnormalities typically begin to
develop in young adults, the CARDIA participants will provide researchers with an excellent
study population. As part of the CARDIA study, ECGs were obtained from participants at
baseline, and Years 7 and 20. Study researchers will use state-of-the-art technology and
standardized Minnesota Code and Novacode methods to electronically code participants' ECGs
and accomplish the following: 1) assess the frequency of ECG abnormalities in young adults
of different races; 2) examine potential risk factors for the development and progression of
ECG abnormalities; 3) investigate the relationship between ECG abnormalities and other
measures of heart disease; and 4) assess differences in the frequency and patterns of ECG
abnormalities between different racial groups. Study researchers will also analyze
additional CARDIA study data, including cardiovascular disease risk factors, measures of
atherosclerosis, and echocardiographic ultrasound pictures of the heart.
This research will provide important insights into the ways in which ECG abnormalities are
associated with increased risk for cardiovascular disease and how the risk may differ
between blacks and whites. Results from this study may ultimately lead to improvements in
preventive strategies for cardiovascular disease in young adults.
;
Observational Model: Cohort, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|